Results 131 to 140 of about 23,635 (276)

Successful induction treatment of bullous pemphigoid using reslizumab: a case report [PDF]

, 2021
Hyo‐In Rhyou, Song‐Hee Han, Young‐Hee Nam   +2 more
openalex   +1 more source

Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms

JID Innovations
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel ...
Olive C. Osuoji, Taryn DeGrazia, Robin Rolader, Emily F. Cole, Katy Lawson, Henry Hilley, Yanyan Xing, Liang Han, Sarah Chisolm, Henry Claussen, Xiaobo Yan, Yuxian Sun, Yuan Liu, Suephy C. Chen, Ron J. Feldman   +14 more
doaj   +1 more source

Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01 [PDF]

, 2020
Arata Hibi, Yuto Kasahara, Y. Ishihara, Koichi Hata, Norihisa Hosokawa, Takahiko Nakagawa   +5 more
openalex   +1 more source

Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran

Acta Medica Iranica, 2018
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi, Maryam Daneshpazhooh, Hamidreza Mahmoudi, Maryam Nasimi, Alireza Delavari, Arghavan Azizpour   +5 more
doaj  

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

JEADV Clinical Practice
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy   +2 more
doaj   +1 more source

Non-bullous pemphigoid associated with immune checkpoint inhibitor treatment [PDF]

, 2021
Akiyoshi Senda, Takaya Komori, Yoshihiro Ishida, Teruasa Murata, Atsushi Otsuka, Kenji Kabashima   +5 more
openalex   +1 more source

Brunsting-Perry Pemphigoid of the Scalp with Antibodies against Laminin 332 [PDF]

, 2011
A. Niedermeier, Bekou V, Bruch-Gerharz D, Brunsting LA, Chan LS, Choi GS, Daito J, H. Jedlickova, Joly P, Kurzhals G, Lazarova Z, M. Hertl, Monihan JM, Murata Y, Poon E, S. Zgažarová, Tasanen K   +16 more
core   +1 more source

Bullous Pemphigoid in an Elderly Patient with Myelodysplastic Syndrome and Refractory Anemia Coupled with Excess of Blast [PDF]

, 2011
Yin Yin Lee, Ping Chong Bee, Chew Kek Lee, Manimalar Naiker, Rokiah Ismail   +4 more
openalex   +1 more source

Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation [PDF]

, 2022
Khalaf Kridin, Orly Avni, Giovanni Damiani, Dana Tzur Bitan, Erez Onn, Orly Weinstein, Arnon D. Cohen   +6 more
openalex   +1 more source

Childhood bullous pemphigoid [PDF]

Indian Pediatrics, 2013
Dipti, Das, Anupam, Das, Panchami, Debbarman   +2 more
openaire   +2 more sources